Characterization of genetic instability in radiation- and benzene-induced murine acute leukemia

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 428, Issue 1-2, 1999, Pages 33-39

  Rithidech, Kanokporn ^a   Dunn, John J ^b   Bond, Victor P ^c   Gordon, Chris R ^a   Cronkite, Eugene P ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Benzene; Fluorescence in situ hybridization (FISH); G banding; Genetic instability; Leukemia; Radiation

Indexed keywords

BENZENE;

ACUTE LEUKEMIA; CHROMOSOME 2; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CONFERENCE PAPER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENETIC STABILITY; HUMAN; LEUKEMOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION; RAT;

ANIMALS; BENZENE; CHROMOSOME BANDING; CHROMOSOME DELETION; DISEASE MODELS, ANIMAL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, EXPERIMENTAL; LEUKEMIA, RADIATION-INDUCED; MALE; MICE; MICE, INBRED CBA; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE;

EID: 0032774625     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(99)00029-0     Document Type: Conference Paper

References (63)

1. UNSCEAR. Sources and effects of ionizing radiation. United Nations Scientific Committee on the effects of atomic radiation, United Nations, New York, (1977).
2. W.M. Court-Brown, R. Doll, Leukemia and aplastic anemia in patients irradiated for ankylosing spondylitis. Medical Research Council Special Report Series #295, HSO (1957) 1-135.
3. Levine E.G., Bloomfield C.D. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin. Oncol. 19:1992;47-84.
4. Infante P.F., White M.C. Benzene: epidemiologic observations of leukemia by cell type and adverse health effects associated with low-level exposure. Environ. Health Perspect. 52:1983;75-82.
5. Aksoy M. Benzene as a leukemogenic and carcinogenic agent. Am. J. Ind. Med. 8:1985;9-20.
6. Rithidech K., Cronkite E.P., Bond V.P. Advantages of the CBA mouse in leukemogenesis research. Blood Cells, Mol. Dis. 25(3):1999;38-46.
7. Rithidech K., Bond V.P., Cronkite E.P., Thompson M.H. A specific chromosomal deletion in murine leukemic cells induced by radiation with different qualities. Exp. Hematol. 21:1993;427-431.
8. Farris G.M., Everitt J.I., Irons R.D., Popp J.A. Carcinogenicity of inhaled benzene in CBA mice. Fund. Appl. Toxicol. 20:1993;503-507.
9. Boggs D.R. Clonal origin of leukemia site of origin in the stem cell hierarchy and the significance of chromosomal changes. Blood Cells. 7:1981;205-215.
10. Ueda T., Kita K., Kagawa D.et al. Acute leukemia with two cell populations of lymphoblasts and monoblasts. Leukemia Res. 8:1984;63-69.
11. Das Gupta A., Advant S.H., Nair C.N. Acute leukemia with coexpression of lymphoid and myeloid phenotypes. Hematol. Oncol. 5:1987;189-196.
12. Schmitt-Graff A., Jurgen H., Reifenhauser A., Schwamborn D., Gobel U. Childhood biphenotypic leukemia: detection of mixed lymphoid and myeloid populations in bone marrow specimens. Human Pathol. 19:1988;651-656.
13. Keinanen M., Griffin J.D., Bloomfield C.D., Machniki J., De La Chapelle A. Clonal chromosomal abnormalities showing multiple-cell-lineage involvement in acute myeloid leukemia. N. Engl. J. Med. 318(18):1988;1153-1158.
14. Cuneo A., Michaux J.-L., Ferrant A., Hove L.V., Bosly A., Stul M., Cin P.D., Vandenberghe E., Cassiman J.J., Negrini M., Piva N., Castoldi G., Berghe H.V.D. Correlation of cytogenetic patterns and clinicobiological features in adult acute myeloid leukemia expressing lymphoid markers. Blood. 79(3):1992;720-727.
15. Bold D.H., Kopecky K.J., Head D., Gehly G., Radich J.P., Appelbaum F.R. Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adult. The Southwest oncology group experience. Leukemia. 8(12):1994;2118-2126.
16. Lim S.H., Culligan D., Couzens S., Fisher J., John S., Pollard P. Molecular evidence for a common leukemic progenitor in acute mixed lymphoid and myeloid leukemia. Br. J. Haematol. 92:1996;131-133.
17. Khalidi H.S., Medeiros L.J., Chang K.L., Brynes R.K., Slovak M.L., Arber D.A. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities. Am. J. Clin. Pathol. 109(2):1997;211-220.
18. Hayata I., Seki M., Yoshida K., Hirashima F., Sado F., Yamagiwa J., Ishihara T. Chromosomal aberrations observed in 52 mouse myeloid leukemias. Cancer Res. 43:1983;367-373.
19. G. Breckon, A.R.J. Silver, R. Cox, Consistent chromosome changes in radiation-induced murine leukemias, in: P.E. Brandham, M.D. Bennet (Eds.), Kew chromosome conference III. HMSO, London (1988) 179-184.
20. Trakhtenbrot L., Krauthgamer R., Resnitsky P., Haran-Gheran N. Deletion of chromosome 2 is an early event in the development of radiation-induced myeloid leukemia in SJL/J mice. Leukemia. 2:1988;545-550.
21. Bouffler S.D., Breckon G., Cox R. Chromosomal mechanisms in murine radiation acute myeloid leukemogenesis. Carcinogenesis. 17:1996;655-659.
22. Bouffler S.D., Meijne E.I.M., Huiskamp R., Cox R. Chromosomal abnormalities in neutron-induced acute myeloid leukemias in CBA/H mice. Radiat. Res. 146:1996;349-352.
23. Rithidech K., Bond V.P., Cronkite E.P., Thompson M.H., Bullis J.B. Hypermutability of mouse chromosome 2 during the development of X-ray-induced murine myeloid. Proc. Natl. Acad. Sci. 92:1995;1152-1156.
24. Committee on standardised Genetic Nomenclature for mice Standard karyotype of the mouse, Mus musculus. J. Hered. 63:1972;69-72.
25. Cowell J.K. A photographic representation of the variability in the G-banded structure of chromosomes in the mouse karyotype. Chromosoma. 89:1984;294-320.
26. Rowley J.D., Potter D. Chromosomal banding patterns in acute leukemia. Blood. 47:1976;705-722.
27. Smith M.T., Zhang L., Wang Y., Hayes R.B., Li G., Wiemels J., Dosemeci M., Titenko-Holland N., Xi L., Kolachana P., Yin S., Rothman N. Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene. Cancer Res. 58:1998;2176-2181.
28. Irons R.D., Neptun D.A., Pfeifer R.W. Inhibition of lymphocytes transformation and microtubule assembly by quinone metabolites of benzene: evidence for a common mechanism. J. Reticuloendothel. Soc. 30:1981;359-372.
29. Eastmond D.A., Rupa D.S., Hasegawa L.S. Detection of hyperdiploidy and chromosome breakage in interphase human lymphocytes following exposure to benzene metabolite hydroquinone using multicolor fluorescence in situ hybridization with DNA probes. Mutat. Res. 322(1):1994;9-20.
30. Zhang L., Venkatesh P., Creek, Smith M.T. Detection of 1,2,4-benzenetriol induced aneuploidy and microtubule disruption by fluorescence in situ hybridization and immunocytochemistry. Mutat. Res. 320(4):1994;315-327.
31. Bonomi R., Le Coniat M., Berger R. Is trisomy 4 a secondary chromosomal abnormality in acute myeloblastic leukemia. Cancer Genet. Cytogenet. 79(2):1995;186-187.
32. Reddy K.S., Sulcova V. c-myc amplification in a preleukemic patient with trisomy 4 and double minutes: review of the unique coexistence of these two chromosome abnormalities in acute myelogenous leukemia. Cancer Genet. Cytogenet. 95(2):1997;206-209.
33. Keung Y.K., Kaplan B., Douer D. Biphenotypic M0 acute myeloid leukemia with trisomy. Leuk. Lymphoma. 14(1 to 2):1994;181-184.
34. Gull G.M., Howe D.J., Stack-Dunne M., Phillips M.J., Johnson S.A. Tetrasomy of chromosome 8 in a patient with acute myeloid leukemia. Leuk. Lymphoma. 19(3 to 4):1995;355-358.
35. Shao J., Zhang L., Semenza J.C., Beach B., Smith M.T. Tetrasomy 8 detected by interphase cytogenetics in a child with acute lymphocytic leukemia. Cancer Genet. Cytogenet. 92(2):1996;135-140.
36. Amiel A., Elis A., Manor Y., Tangi I., Fejgin M., Lishner M. Fluorescence in situ hybridization (FISH) for the detection of trisomy 8 in acute myeloblastic leukemia. Leuk. Lymphoma. 23(5 to 6):1996;603-607.
37. Cuneo A., Bigoni R., Robert M.G., Bardi A., Rigolin G.M., Piva N., Mancini M., Nanni M., Alimena G., Mecucci C., Matteucci C., Starza R., Bernasconi P., Cavigliano P., Genini E., Zaccaria A., Testoni N., Carboni, Castoldi G. Detection and monitoring of trisomy 8 by fluorescence in situ hybridization in acute myeloid leukemia: a multicentric study. Haematologica. 83(1):1998;21-26.
38. Collins K.J. Acute myeloid leukemia in patients with trisomy 21. J. Paediatr. Child Health. 31(1):1995;57-61.
39. Wei C.H., Yu I.T., Tzeng C.H.et al. Trisomy 21 in acute myeloid leukemia. Cancer Genet. Cytogenet. 86(2):1996;177-180.
40. Berger R. Acute lymphoblastic leukemia and chromosome 21. Cancer Genet. Cytogenet. 94(1):1997;8-12.
41. Wiener F., Spira J., Ohno S., Haran-Ghera N., Klein G. Chromosome changes (trisomy 15) in murine T-cell leukemia induced by 7,12-demethylbenz(a)anthracene (DMBA). Int. J. Cancer. 22:1978;447-453.
42. Wiener F., Ohno S., Spira J., Haran-Ghera N., Klein G. Cytogenetic mapping of the trisomic segment of chromosome 15 in murine T-cell leukemia. Nature. 275:1978;658-660.
43. Spira J., Weiner F., Babonits M., Gamble J., Miller J., Klein G. The role of chromosome 15 in murine leukemogenesis: I. Contrasting behavior of the tumor vs. normal parent-derived chromosome no. 15 in somatic hybrids of varying tumorigenicity. Int. J. Cancer. 28:1981;785-789.
44. Mouse Genome Informatics (MGI) Resource, Mouse Genome Informatics, The Jackson Laboratory, Bar Harbor, Maine. World Wide Web (URL:htttp//www.informatics.jax.org/) January, 1999.
45. Fennelly J., Crabtree G., MacDonald D., Lorimore S., Laval S., Proffitt J., Boyd Y., Wright E., Plumb M. Complex Y chromosome aberrations are a recurrent secondary event in radiation induced murine acute myeloid leukemia. Leukemia. 9:1995;506-512.
46. Plumb M., Harper K., MacDonald D., Fennelly J., Lorimore S., Wright E. Ongoing Y-chromosome instability defines sub-clonal variants in radiation-induced leukemias in the mouse. Int. J. Radiat. Biol. 72(1):1997;1-9.
47. Grozdea J., Kessous A., Colombies P. Leukemia and loss of Y chromosome. Lancet. 2(7827):1973;506.
48. Padre-Mendoza T., Farnes P., Barker B.E., Smith P.S., Forman E.N. Y chromosome loss in childhood leukemias. Br. J. Haematol. 41(1):1979;43-48.
49. Meleltis J., Samarkos M., Abazis D., Michali E., Vavourakis S., Plata E., Rombos J., Konstantopoulos K., Pangalos K., Yataganas X., Loukopoulos D. Trisomy 11 with loss of the Y chromosome and trisomy 13 in a case of de novo acute myeloid leukemia. Cancer Genet. Cytogenet. 86(1):1996;65-68.
50. Sinclair E.J., Potter A.M., Watmore A.E., Fitchett M., Ross F. Trisomy 15 associated with loss of the Y chromosome in bone marrow: a possible new aging effect. Cancer Genet. Cytogenet. 105(1):1998;20-23.
51. Sandberg A.A., Turc-Carel C., Gemmill R.M. Chromosomes in solid tumors and beyond. Cancer Res. 48:1988;1049-1059.
52. Cremer T., Lichter P., Borden J., Ward D.C., Manuelidis L. Detection of chromosome aberrations in metaphase and interphase tumor cells by in situ hybridization using chromosome specific library probes. Hum. Genet. 80:1988;235-246.
53. Lucus J.N., Tenjin T., Straume T., Pinkel D., Moore I.I., Litt M., Gray J.W. Rapid determination of human chromosome translocation frequency analysis in humans decade after exposure to ionizing radiation. Int. J. Radiat. Biol. 56:1989;35-44.
54. Eastmond D.A., Pinkel D. Detection of aneuploidy and aneuploidy-inducing agents in human lymphocytes using fluorescence in situ hybridization with chromosome-specific DNA probes. Mutat. Res. 234:1990;303-318.
55. Gray J.W., Pinkel D., Brown J.M. Fluorescence in situ hybridization in cancer and radiation biology. Radiat. Res. 137:1994;275-289.
56. Breneman J.W., Swiger R.R., Ramsey M.J., Minkler J.L., Eveleth G.G., Langlois R.A., Tucker J.D. The development of painting probes for dual color and multiple chromosome analysis in the mouse. Cytogenet. Cell Genet. 68:1995;197-202.
57. Rabbits P., Impey H., Heppell-parton C., Longford, Tease C., Lowe N., Bailey D., Ferguson-Smith, Carter N. Chromosome specific paints from a high resolution flow karyotype of the mouse. Nature Genet. 9:1995;369-375.
58. Spruill M.D., Ramsey M.J., Swiger R.R., Nath J., Tucker J.D. The persistence of aberrations in mice induced by gamma radiation as measured by chromosome painting. Mutat. Res. 356:1996;135-145.
59. Hande M.P., Boei J.J., Granath W.A., Natarajan A.T. Induction and persistence of cytogenetic damage in mouse splenocytes following whole-body X-irradiation analysed by fluorescence in situ hybridization: I. Dicentrics and translocations. Int. J. Radiat. Biol. 69(4):1996;437-446.
60. Edstrom J.E., Kaiser R., Rohme D. Microcloning of mammalian metaphase chromosomes. Methods Enzymol. 151:1987;503-516.
61. K. Rithidech, C.R. Gordon, J.J. Dunn, Construction of a painting probe specific for regions D and E of mouse chromosome 2, (1999) in preparation.
62. Telenius H., Carter N.P., Bebb C.B., Nordenskjold M., Ponder B.A., Tunnacliff A. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics. 13(3):1992;718-725.
63. Guan X.Y., Trent J.M., Meltzer P.S. Generation of band-specific painting probes from a single microdissected chromosome. Hum. Mol. Genet. 2(8):1993;1117-1121.